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The transcriptional control of CD1d-restricted NKT
cell development has remained elusive. We report
that PLZF (promyelocytic leukemia zinc finger,
Zbtb16), amember of the BTB/POZ-ZF family of tran-
scription factors that includes the CD4-lineage-spe-
cific c-Krox (Th-POK), is exquisitely specific to
CD1d-restricted NKT cells and human MR1-specific
MAIT cells. PLZFwas induced immediately after pos-
itive selection of NKT cell precursors, and PLZF-de-
ficient NKT cells failed to undergo the intrathymic
expansion and effector differentiation that character-
ize their lineage. Instead, they preserved a naive
phenotype and were directed to lymph nodes. Con-
versely, transgenic expression of PLZF induced
CD4+ thymocytes to acquire effector differentiation
and migrate to nonlymphoid tissues. We suggest
that PLZF is a transcriptional signature of NKT cells
that directs their innate-like effector differentiation
during thymic development.
INTRODUCTION
The development of thymic ab T cell lineages relies on signaling
processes that are initiated upon T cell receptor (TCR) engage-
ment by MHC or MHC-like ligands at the CD4+CD8+ double pos-
itive (DP) stage (reviewed inHeand Kappes, 2006; Singerand Bos-
selut, 2004). Although overlapping with their positive selection, the
lineage commitment of thymocytes can be separated and manip-
ulated on the basis of the expression of signature components of
transcriptional networks involved in lineage decisions. For exam-
ple, the antagonistic expression and function of c-Krox (Th-POK)
and Runx3 define the CD4 and CD8 lineages, respectively (He
et al., 2005; Setoguchi et al., 2008; Sun et al., 2005; Wildt et al.,
2007). A fraction of MHC class-II-restricted CD4+ T cells further
differentiates into CD25+ regulatory T cells characterized by the
transcription factor Foxp3 (Fontenot et al., 2003; Hori et al., 2003).
Little is known, however, about the transcriptional regulation
of unconventional ab T cell lineages, such as NKT cells, MAIT
cells, or CD8aa intraepithelial lymphocytes (reviewed in Bende-
lac et al., 2007; Shires et al., 2001; Treiner and Lantz, 2006).
There is evidence suggesting that their TCRs engage in higherImavidity interactions with self ligands than conventional T cells, re-
sulting in the acquisition of a permanently activated effector or
memory phenotype. However, it remains unknown whether their
resulting transcriptional profile is a mere combination of those al-
ready described for conventional naive T cells and their various
memory and effector products (Matsuda et al., 2006; Shires
et al., 2001) or whether essential signature transcription factors
are induced, transiently or permanently, during the thymic devel-
opment of these lineages.
NKT cells are a well-characterized conserved population of
T cells that express mainly CD1d-restricted ab TCRs made of an
invariant Va14-Ja18 chain in mouse (Va24-Ja18 in human), com-
bined with variable Vb8, Vb7, and Vb2 chains (Vb11 in human) (re-
viewed in Bendelac et al., 2007; Godfrey and Berzins, 2007) that
recognize conserved self and foreign glycosphingolipids. Essen-
tial to their innate-like function in the mammalian immune system
are the massive expansion that rare NKT cell precursors undergo
in the thymus upon interaction with CD1d ligands and their subse-
quent acquisition of an effector phenotype along with receptors of
the NK cell lineage. The effector functions are characterized by
their peculiar ability to explosively release both IL-4 and IFN-g.
The cellular stages of NKT cell development have been exten-
sively characterized (reviewed in Bendelac et al., 2007). Rare DP
precursors expressing a canonical semi-invariant TCR interact
with CD1d ligands expressed by cortical thymocytes and, in the
process, engage homophilic interactions between SLAM family
receptors, which provide essential signals through the adaptor
SAP, the Src kinase Fyn, and downstream NF-kB. The signaled
DPs reach a CD24hi CD4+ CD8lo CD69hi stage, termed ‘‘stage
0,’’ similar to the ‘‘transitional’’ CD4+ stage attained by positively
selected conventional CD4+ and CD8+ T cells. NKT cell precur-
sors then mature by downregulating CD24 and CD8 to reach
a mature CD4+ stage with a naive CD44lo phenotype (‘‘stage
1’’), similar to conventional CD4+ cells. Unlike conventional
CD4+ cells, which egress the thymus as naive cells, stage 1
NKT cells remain in the thymus and immediately engage in multi-
ple rounds of cell division, activating low basal transcription of T
helper 2 (Th2) cell followed by Th1 cell cytokines. This expansion
is accompanied by the induction of CD44, a marker of antigen-ex-
perienced T cells, and of theb chain of the IL-15 receptor, which is
induced by the transcription factor T-bet (‘‘stage 2’’). Upon egress
from the thymus, these stage 2 NKT cells further differentiate to
stage 3 cells that express a panoply of NK cell lineage receptors,
including NK1.1, NKG2D, CD94, and inhibitory Ly49 isotypes. In
mouse, a population of NKT thymocytes fail to migrate and persistmunity 29, 391–403, September 19, 2008 ª2008 Elsevier Inc. 391
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PLZF Directs NKT Cell DevelopmentFigure 1. PLZF Expression Is Specific to NKT Cells
(A) Purified subsets of splenocytes and intestinal intraepithelial lymphocytes as indicated were assessed for PLZF mRNA expression by qRT-PCR. "FoB" indi-
cates follicular B cells; "MzB" indicates marginal zone B cells. Data are shown as mean ± SD of triplicate PCR values.
(B) PLZF and c-Krox mRNA expression in thymic subsets and thymic NKT cell developmental stages as indicated. DN: CD48 double negative; DP: CD4+8+
double positive; trnsl CD4: transitional CD4+8loCD24hiTCRbhi; CD4SP: CD4+8- single positive; NKT cell stage 0: CD24hiCD69hi; NKT cell stage 1: CD24lo
CD44loNK1.1-; NKT cell stage 2: CD24loCD44hiNK1.1; NKT cell stage 3: CD24loCD44hiNK1.1+. Data are shown as mean ± SD of triplicate PCR analysis
and are representative of two to three independent experiments.
(C) PLZF immunoblot analysis of sorted CD1d-aGalCer+ NKT cells and conventional CD4 and CD8 cells (1 3 106 cells per lane) in the thymus and spleen, as
indicated. Anti g-tubulin was used as a loading control. Data are representative of three experiments.
(D) Intracellular flow cytometry with anti-PLZF mAb D-9 of thymic NKT stage 1 and 2 cells (Tetr+NK1.1; gray shaded), stage 3 cells (Tetr+NK1.1+; black shaded),
and conventional T cells (TCRb+Tetr), as indicated. The isotype control is the dashed histogram. Data are representative of four experiments.as resident stage 3 cells in the thymus. Peripheral NKT cells pref-
erentially reside in the liver, continuously crawling along the sinu-
soidal endothelial cells (Geissmann et al., 2005; Godfrey and Ber-
zins, 2007), but they are also present in the spleen, lymph nodes,
bone marrow, lung, and gut. The homeostatic signals regulating
their prolonged lifespan are mediated by IL-15, as is the case
for other memory and effector T cells and NK cells.
Studies of mice lacking transcription factors such as Ets-1
family members (Lacorazza et al., 2002; Walunas et al., 2000),
Runx proteins (Egawa et al., 2005), Gata-3 (Kim et al., 2006),
and T-bet (Matsuda et al., 2006) showed partial defects of NKT
cells as well as T cells and NK cells (Egawa et al., 2007; Intlekofer
et al., 2005; Lacorazza et al., 2002; Pai et al., 2003; Samson et al.,
2003; Taniuchi et al., 2002; Townsend et al., 2004). NF-kB fac-
tors are important for completion of the NKT cell intrathymic ex-
pansion phase (Sivakumar et al., 2003; Stanic et al., 2004) but are
also involved in multiple other lymphocyte lineages and differen-
tiation programs (Hayden and Ghosh, 2008). It has remained
a challenge, therefore, to determine whether some transcription392 Immunity 29, 391–403, September 19, 2008 ª2008 Elsevier Inc.factors might be specifically expressed in NKT cells and contrib-
ute to their development in a unique manner.
Here,we identifiedPLZF(promyelocytic leukemiazincfinger,en-
coded byZbtb16) as a specific transcriptional regulator of NKT cell
development. The absence of PLZF abrogated both the expansion
and the effector differentiation of NKT cells, resulting in their rever-
sal to a naive phenotype and their tissue redistribution to the lymph
nodes rather than the liver. Conversely, ectopic expression in the
CD4 lineage converted CD4+ thymocytes into effector cells that
preferentially migrated to nonlymphoid tissues. Thus, we conclude
that PLZF is a transcriptionalsignature ofNKT cells that directs their
innate-like effector differentiation during thymic development.
RESULTS
Selective Expression of PLZF in CD1d-Restricted
NKT Cells
To identify the transcription factors involved in NKT cell develop-
ment, we performed a microarray screen on sorted NKT cells
Immunity
PLZF Directs NKT Cell DevelopmentFigure 2. Luxoid Mice Have a Selective Defect in NKT Cell Development
(A) The frequency of NKT cells in the thymus, spleen, and liver of Zbtb16lu/lu (lu/lu) mice compared to their WT/WT littermate controls. NKT cells were gated (as
shown) as CD24loCD1d-aGC+ in the thymus and as CD1d-aGC+TCRb+ (or CD1d-aGC+B220 in some experiments) in the spleen and liver. Data are represen-
tative of six pairs of mice.
(B) Summary of NKT cell absolute numbers in individual thymuses, spleens, and livers of WT/WT and lu/lu littermates. Asterisk: p % 0.05; double asterisk:
p% 0.01.
(C) Unconventional intestinal IELs in lu/lu mice and their WT/WT littermates. Upper row: frequency of ab and gd T cells among CD3+ gated IELs; lower row:
frequency of CD8aa and CD8ab T cells among TCRb+ gated IELs. Absolute numbers of IELs were similar in WT/WT and lu/lu mice. Data are representative
of five littermate pairs in two independent experiments.from C57BL/6 mice. Numerous probe sets mapping to Zbtb16
showed conspicuous overexpression in comparison to naive
and activated conventional CD4+ and CD8+ T cells (data not
shown). Similar results can be observed in microarray experi-
ments published online (http://www.immgen.org). Quantitative
PCR (qPCR) confirmed that PLZF transcripts were highly ex-
pressed in splenic NKT cells purified with specific CD1d-
aGalCer tetramers and were low or absent in other splenic pop-
ulations, including CD4+ and CD8+ T cells, CD25+ regulatory
T cells, NK cells, and follicular- and marginal-zone B cells
(Figure 1A). Strikingly, PLZF was low also in unconventional
T cell lineages that constitutively express an effector phenotype.
These lineages included intestinal intraepithelial lymphocytes
(iIEL) expressing the ab TCR along with CD8aa homodimers
(CD8aa) or CD8ab heterodimers (CD8ab) or expressing the gd
TCR (Figure 1A). Likewise, PLZF transcripts were low or absent
in conventional CD44hi (memory) CD4 and CD8 spleen cells or
in Th1 and Th2 cells derived from splenic CD4+ cells stimulated
with anti-CD3 along with cytokine and anti-cytokine cocktails
(data not shown; http://www.immgen.org).
To determine the stage of NKT cell development when PLZF is
induced, we purified the different NKT cell stages from the
mouse thymus using CD1d-aGalCer tetramers. All CD24lo
stages of NKT cell development from the CD44lo NK1.1- naiveI(stage 1) to CD44hi NK1.1- effector (stage 2) to the terminally dif-
ferentiated CD44hi NK1.1+ (stage 3) expressed high amounts of
PLZF (Figure 1B). Stage 3 cells in the thymus, as in the spleen,
consistently expressed lower amounts than did stage 1 and
stage 2 thymic cells. The earliest NKT cell precursors (so-called
stage 0) can be identified as CD24hi tetramer+ cells that are uni-
formly CD69hi and correspond to a mixture of CD4loCD8lo (DPlo)
and CD4+CD8lo cells that immediately follow positive selection
(Benlagha et al., 2005). These cells, which are present at a low
frequency of approximately 300 cells per thymus, were MACS-
enriched on the basis of CD1d-aGalCer tetramer staining from
large pools of mice and were further purified by flow-cytometry
sorting. As shown in Figure 1B, high expression of the PLZF tran-
script was already detected at this early stage. In comparison,
sorted CD4+ CD8lo thymocytes, the so-called transitional CD4
cells that represent postselection CD69hi precursors of both
CD4 and CD8 lineage cells, exhibited low or undetectable tran-
script, similar to DN, DP, and mature CD4 SP thymocytes
(Figure 1B). Thymic CD25+ regulatory T cells and gd T cells
also expressed low amounts of PLZF (data not shown).
The CD4-lineage-determining factor c-Krox (Th-POK, en-
coded by Zbtb7b), which belongs to the same family of BTB/
POZ-ZF as PLZF, was also expressed at all stages of NKT
cell development, starting immediately after positive selectionmmunity 29, 391–403, September 19, 2008 ª2008 Elsevier Inc. 393
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PLZF Directs NKT Cell DevelopmentFigure 3. Mixed Bone-Marrow Chimeras Reveal a Cell-Intrinsic NKT Cell Defect
(A) CD45.2 lu/lu and CD45.1 WT/WT bone marrows were mixed at a 1:1 ratio and transferred into lethally irradiated Ja18-deficient hosts. Six to eight weeks later,
reconstituted animals were analyzed by flow cytometry. Individual thymuses and spleens from the chimeras were MACS-enriched with CD1d-aGC tetramers
prior to FACS analysis of NKT cell developmental subsets. The leftmost row of the upper panel shows the relative proportion of CD45.2 (lu/lu) and CD45.1
(WT) NKT cells in the thymus; the right panels show the proportion of CD24hi (stage 0) and CD24lo (stages1, 2, and 3) cells in the total population (second panel
from left) and in gated CD45.1 (WT) (third panel) and CD45.2 (lu/lu) (fourth panel) CD1d-aGC+ cells. WT and lu/lu CD24lo NKT cells were further analyzed on the394 Immunity 29, 391–403, September 19, 2008 ª2008 Elsevier Inc.
Immunity
PLZF Directs NKT Cell Developmentin stage 0 cells (Figure 1B). This expression mimics the pattern
observed for conventional CD4+ T cells and is consistent
with the CD4+ phenotype of stage 0 and stage 1 NKT cell precur-
sors.
To determine protein expression, we performed immunoblot-
ting on sorted cell populations using a polyclonal antibody spe-
cific for the C-terminal region of PLZF. A protein with the expected
80–90 kD molecular weight was easily detected in thymic NKT
cells and, at a weaker amount, in splenic NKT cells, whereas con-
ventional CD4+ and CD8+ cells had undetectable amounts
(Figure 1C). At the single cell level, intracellular flow cytometry
with the mAb D-9 demonstrated expression in all CD1d-aGalCer
tetramer-positive thymocytes, with high levels in NK1.1-negative
NKT thymocytes (stage 1 and 2) and intermediate levels in NK1.1-
positive cells (stage 3). In contrast, PLZF was undetectable in
control single-positive thymocytes (Figure 1D).
Altogether, these results demonstrate the highly specific ex-
pression of PLZF in NKT cells and its early induction during thy-
mic development, concomitant with positive-selection events.
Selective Defect of NKT Cell Development
in PLZF-Deficient Mice
The Luxoid mutation arose spontaneously in a C3H/He line and
was identified on the basis of skeletal abnormalities and male
sterility (Green, 1961). Luxoid represents a single base pair C-
to-T transition that converts Arginine 234 to a nonsense codon,
resulting in a protein that encompasses the BTB/POZ domain
but lacks the other domains, including the DNA-binding region
with all nine zinc fingers (Buaas et al., 2004). The Luxoid mice
used in this study were backcrossed > 30 times into C57BL/6.
Heterozygous Luxoid mice were intercrossed for generation of
homozygous mutants (designated Zbtb16lu/lu) and examination
of their lymphoid compartments. Zbtb16lu/lu littermates exhibited
a drastic 90%–99% decrease in NKT cells stained by specific
CD1d-aGalCer tetramers in the thymus, spleen, and liver in
4- to 8-week-old mice (Figures 2A and 2B). Other lymphocyte
populations in the thymus, the spleen, and peripheral lymph no-
des, including conventional naive and memory CD4+ and CD8+
T cells, B cells, NK cells, and CD11c+MHC II+ and CD11b+ den-
dritic cells and macrophages, were unaffected (Figure S1 and
data not shown). Notably, unconventional T cell subsets, includ-
ing thymic gd T cells (not shown) and all three intestinal intraepi-
thelial effector lineages (TCRgd, CD8aa TCRab, CD8ab TCRab),
were preserved (Figure 2C).
Intrinsic Defect of NKT Cell Precursors Revealed
by Mixed Bone-Marrow Chimeras
For the determination of whether the NKT cell defects were
intrinsic to the NKT cell lineage or related to defects in their en-
vironment, B6.Ja18-deficient or B6 mice were lethally irradiated
and reconstituted with a 1:1 or 1:3 mixture of CD45 allotype-Immarked wild-type (WT) and lu/lu bone marrow cells. Whereas
the WT and the lu/lu bone marrows showed a similar potency
for generation of myeloid and lymphoid lineages in these com-
petitive chimeras, the lu/lu NKT cells were selectively decreased
by 87%–97% on average in the thymus, spleen, and liver com-
pared to WT (Figures 3A and 3B). lu/lu cells, however, did not
show impaired generation of naive or memory CD4+ and CD8+
T cells (Figure S1A). Upon short-term culture with anti-CD3
and polarizing cocktails of cytokines and anti-cytokine anti-
bodies, the splenic CD4+ T cells derived from the WT and the
lu/lu compartments of these mixed chimeras expanded and po-
larized equivalently, further confirming that PLZF does not play
a major role in conventional T cell expansion or differentiation
into Th1 or Th2 effector cell subsets (Figure S1B). These findings
establish, therefore, the intrinsic and highly specific nature of the
developmental defect of NKT cell precursors in mice lacking
PLZF.
Early Stage of the NKT Cell-Development Defect
To precisely and quantitatively determine the stages of NKT cell
development affected by the absence of PLZF, we examined the
thymus of the mixed bone-marrow chimeras after NKT cell en-
richment using MACS and CD1d-aGalCer tetramers (Figure 3).
CD45.1 WT and CD45.2 lu/lu cells were analyzed for their ex-
pression of CD24 for enumeration of the earliest identifiable
CD24hi stage 0 cells that are the immediate CD69hi product of
positive selection, as well as for the expression of CD44 and
NK1.1 following the progression from stage 1 to stage 2 to stage
3 among the CD24lo cells. Stage 0 and stage 1 cells were clearly
quantitatively preserved in the absence of PLZF in these com-
petitive chimeras. In contrast, stage 2 and stage 3 cells were re-
duced to 2%–3% of WT, indicating that the developmental block
occurred precisely prior to the massive intrathymic expansion
and memory-effector formation that characterizes NKT cell de-
velopment (Figures 3A and 3C). Thus, the residual population
found in the lu/lu compartment was predominantly composed
of stage 1 CD44lo cells. Interestingly, a minor population—
amounting to 15%–20%—of these stage 1 thymocytes ex-
pressed low NK1.1, suggesting that some reduced NK cell differ-
entiation might proceed in the absence of cell expansion and
memory-effector formation. In the spleen, a majority of lu/lu
NKT cells expressed the CD44lo naive phenotype, suggesting
that the thymic stage 1 cells were exported and survived in pe-
ripheral tissues. In addition, a population of CD44hi NK1.1+ stage
3-like cells could be identified, suggesting that a minor fraction of
NKT cells were able to terminally differentiate in the absence of
PLZF. Interestingly, these splenic stage 3-like cells exhibited
an increase in the proportion of CD4 (DN) cells (Figure 3A, bot-
tom row), suggesting a role of PLZF in the maintenance of CD4
expression in the NKT cell lineage.basis of CD44 and NK1.1 expression or CD44 and CD4 expression, as indicated for the thymus and spleen (bottom two rows). Data are representative of six
individual chimeras.
(B) Summary of CD1d-aGC+ cell numbers in the WT/WT and lu/lu compartments of individual mixed chimeras. Data are normalized on the basis of the relative
level of reconstitution by CD45.1 and CD45.2 bone marrows (e.g., NKT cell number in the WT CD45.1 compartment is divided by the CD45.1/(CD45.1 + CD45.2)
ratio measured for total lymphocytes. On average, the WT and lu/lu bone marrows contributed equally to the total lymphocyte population.
(C) Summary of the ratios of WT/WT divided by lu/lu CD1d-aGC+ cells at different stages of thymic development. Data are normalized on the basis of the relative
level of CD45.1 and CD45.2 reconstitution.munity 29, 391–403, September 19, 2008 ª2008 Elsevier Inc. 395
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PLZF Directs NKT Cell DevelopmentFigure 4. PLZF-Deficient NKT Cells Revert to a Naive Phenotype
(A) Summary of the percentages of WT/WT and lu/lu cells among CD1d-
aGalCer+ cells in various tissues of individual mixed bone-marrow chimeras.
The percentages are normalized relative to the level of reconstitution of the to-
tal lymphocyte population by WT/WT and lu/lu cells, as assessed by CD45.1
and CD45.2 staining. For example, the ratio of CD45.1 CD1d-aGalCer+ cells
over the total CD45.1 lymphocyte population is divided by (ratio of
CD45.1+CD1d-aGalCer+ cells divided by the total CD45.1 lymphocyte popula-
tion + ratio of CD45.2+CD1d-aGalCer+ cells divided by the total CD45.2 lym-
phocyte population) and multiplied by 100. *** p% 0.0001.
(B) Expression of CD62L by WT/WT and lu/lu CD1d-aGalCer+ cells in various
tissues of mixed bone-marrow chimeras. The percentage of CD62Lhi cells
among WT or lu/lu CD1d-aGalCer+ cells are indicated in each of the right
quadrants. The percentages of WT and lu/lu cells among total CD1d-aGalCer+
cells are indicated to the right of each dot plot. Data are representative of
5 chimeras.
(C) Cytokine secretion by lu/lu NKT cells. Left, cytokines released after stimu-
lation of 5000 CD1d-aGalCer tetramer-sorted splenocytes (pooled from luxoid
or WT littermates) with anti-CD3 + human IL-2; gray bars: lu/lu cells, black396 Immunity 29, 391–403, September 19, 2008 ª2008 Elsevier Inc.PLZF-Deficient NKT Cells Are Redistributed
to Peripheral Lymph Nodes and the Spleen
Although PLZF-deficient NKT cells were massively reduced in
peripheral tissue, it was important to quantitatively determine
whether the stage 1-arrested ‘‘naive’’ cells identified in the thy-
mus could be exported and survive in the periphery. Strikingly,
not only were such PLZF-deficient NKT cells found in the periph-
ery, as shown in Figure 3A, but, in some tissues where NKT cells
are normally poorly represented, namely the peripheral lymph
nodes, lu/lu NKT cells were present at the same or higher fre-
quency than their WT counterparts (Figure 4). This surprising re-
sult could be explained by the finding that, unlike the WT cells,
they expressed high amounts of CD62L, the homing receptor
for high endothelial venules in lymph nodes, and, therefore,
were probably being redistributed toward lymph nodes. These
findings demonstrate that the bulk of PLZF-deficient NKT cells
maintain the naive state that characterizes stage 1 cells and sur-
vive in that state without engaging in the subsequent expansion
and effector formation leading to the terminal NKT cell
differentiation.
Attempts to evaluate the functional properties of PLZF-defi-
cient NKT cells are complicated by the rarity of these cells. We
FACS-purified the CD1d-aGalCer tetramer-positive cells ar-
rested at stage 1 from the spleens of lu/lu mice and stimulated
them with anti-CD3 + human IL2, or we enriched these cells
from Va14 transgenic ‘‘414’’ mice (Griewank et al., 2007) made
PLZF-deficient by crossing to Luxoid mutants and stimulated
them with a-GalCer-pulsed BMDC. In both experiments, a con-
spicuous defect of IL-4 production, the characteristic cytokine of
NKT cells, was revealed by comparison with Zbtb16+/+ litter-
mates (Figure 4C). IL-2 was preserved or enhanced, whereas
IFN-g was diminished or absent. Thus, in the absence of PLZF,
NKT cells reverted to a stage resembling that of conventional
CD4+ T cells from which they normally diverge during thymic
development.
Transgenic Expression of PLZF in CD4+ T Cells
To test whether ectopic expression of PLZF would be sufficient
to impart some aspects of the NKT cell-differentiation program
to conventional T cells, we transgenically expressed PLZF under
control of the CD4 promoter. This promoter construct carries the
intronic silencer that suppresses expression in CD8 cells and is
exclusively active in double-positive thymocytes and in CD4-lin-
eage T cells (Sawada et al., 1994). Two independent lines, 1797
and 1960, were studied, and they showed similar results. PLZF-
transgenic mice displayed relatively normal numbers of CD4+
cells in the thymus, spleen, liver, and lung but exhibited a > 10-
fold reduction in the blood and lymph nodes, where the remain-
ing T cells were predominantly CD8 lineage cells (Figure 5A and
data not shown). This striking tissue redistribution was
bars: +/+ littermate cells. A major increase in the IL-2/IL-4 ratio was also ob-
served in a separate experiment comparing tetramer-sorted lu/lu versus WT
splenocytes stimulated with aGalCer-loaded DC. Right, stimulation of 3x105
CD19- and CD8-depleted Va14-Ja18 transgenic ‘414’ splenocytes with
aGalCer-pulsed bone-marrow derived dendritic cells; gray bars: lu/lu 414
cells, black bars: +/+ 414 littermate cells. Supernatants were recovered after
2 days and values are expressed in pg/ml. Data are from an individual lu/lu
and littermate pair.
Immunity
PLZF Directs NKT Cell Developmentassociated in part with the acquisition of a CD44hiCD62Llo phe-
notype by a large cohort of CD4 cells in the thymus, spleen, liver,
and lung. Thus, the frequency of CD44hiCD62Llo cells among
CD4+ cells was increased 5–10 times in transgenic CD4 single-
positive thymocytes, splenocytes, lung, and liver lymphocytes
(Figure 5A and data not shown). Markers of late NKT cell lineage
differentiation, such as CD122, NK1.1, NKG2D, however, were
not expressed (data not shown). In contrast, despite their tran-
sient exposure to PLZF at the DP thymic stage, CD8+ T cells
did not exhibit apparent changes in frequency or phenotype in
PLZF-transgenic mice.
To test whether the changes associated with PLZF expression
in CD4 cells were cell-intrinsic and to rule out the possibility that
they might reflect homeostatic expansion after some CD4-line-
age attrition, 1:1 mixed bone-marrow (WT + PLZF Tg) radiation
chimeras were generated. Even in the presence of competing
WT T cells, the PLZF-transgenic CD4+ cells expressed the
same effector phenotype as observed in transgenic mice
(Figure 5B). Furthermore, WT and PLZF-transgenic progenitors
generated equivalent numbers of CD4+ T cells in the thymus
and in the spleen. Again, the CD8 cells appeared unaltered. Alto-
gether, the data establish that ectopic expression of PLZF in
CD4-lineage cells is sufficient for their cell-intrinsic conversion
into effector-type cells.
The PLZF-transgenic CD4 cells did not appear to be actively
cycling, as shown by the very low level of EdU incorporation in
thymic and splenic CD4 cells after a short pulse in vivo (Figure 5C
and data not shown). As a control, both WT and PLZF Tg DP thy-
mocytes incorporated EdU as expected.
Finally, contrasting with the drastic consequences of ectopic
expression of PLZF in CD4 cells, the overexpression of PLZF
by PLZF-transgenic NKT cells did not seem to induce consistent
changes across the range of tissues examined, including thy-
mus, spleen and liver tissues (Figure 5D).
To examine whether PLZF expression also changed the cyto-
kine-expression profile, transgenic CD4 cells were stimulated
with anti-CD3 + human IL-2. Figure 6A shows that the level of
PLZF protein expressed in transgenic CD4 cells (line 1797) was
close to that normally expressed by stage 1 and stage 2 NKT thy-
mocytes of WT mice. These transgenicCD4 cells produced25–50
times less IL-2 than their WT littermate counterparts (Figure 6B).
Intracellular flow cytometry further revealed a 4- to 6-fold in-
creased frequency of IL-4 and IFN-g double-producer cells in
PLZF-transgenic CD4 cells compared to WT (Figure 6C). Such
high frequency of Th1 and Th2 cell double producers is a distinc-
tive feature of the NKT cell-differentiation program (Bendelac
et al., 2007). These changes are the mirror image of those ob-
served in NKT-lineage cells developing in the absence of PLZF.
MR1-Restricted MAIT Cells Express High Amounts
of PLZF
The other well-characterized natural memory or effector lineage
that is selected by a nonclassical MHC class I-like ligand ex-
pressed on bone-marrow-derived cells in the thymus is the mu-
cosal associated invariant T (MAIT) cell. MAIT cells express
semi-invariant ab TCRs with a canonical Va19-Ja33, in mouse,
or Va7.2-Ja33, in human, that recognize MR1 and accumulate
in the intestinal lamina propria, where they can release Th1 and
Th2 cell cytokines (reviewed in Treiner and Lantz, 2006). AlthoughImMAIT cells are very rare and difficult to purify in mouse, they are
abundantly represented in human peripheral blood, where they
can be enriched with mAbs specific for Va7.2 and CD45RO.
Figure 7A shows that, relative to RO+ (memory) CD4+ or CD8+
T cells, human MAIT cells expressed very high amounts of
PLZF, whether they belonged to the CD4, CD8ab, or DN (defined
as CD4CD8b) subset of MAIT cells. In addition, high amounts
of PLZF were also detected in the DN RO+ TCRab population,
an unusual peripheral-blood lymphocyte (PBL) subset that in-
cludes some Va24 NKT cells and MAIT cells, as well as many
other NKT-like cells expressing diverse TCRs (Porcelli et al.,
1993). As expected, human CD4+ and DN Va24 NKT cells, the ho-
mologs of mouse Va14 NKT cells, also expressed high amounts
of PLZF compared to conventional RA+ naive or RO+ memory
CD4+ and CD8+ T cells (Figure 7B). Altogether, the results dem-
onstrate that expression of PLZF is a highly restricted character-
istic of NKT cells and of their cousin lineage of MAIT cells.
PLZF Expression in SAP-Deficient NKT Cells
The adaptor SAP and its associated tyrosine kinase Fyn control
early development of the NKT cell lineage by transducing signals
emanating from homophilic interactions between SLAM family
receptors, such as SLAM and Ly108, expressed at the surface
of cortical thymocytes (Griewank et al., 2007). SAP-deficient
NKT-lineage cells are arrested at stage 0, suggesting the possi-
bility that SAP signaling may be involved in the induction of PLZF.
Quantitative RT-PCR experiments, however, suggested that this
may not be the case, given that PLZF was already upregulated in
SAP-deficient stage 0 NKT thymocytes (Figure 7C).
DISCUSSION
Although transgenic experiments have demonstrated that the
germline-encoded TCRs and BCRs of innate-like lymphocytes,
including NKT cells, faithfully drive the peculiar effector differen-
tiation and migratory properties of their lineage of origin during
development in the thymus or bone marrow (reviewed in Bend-
elac et al., 2001), the transcriptional networks resulting from
these interactions and governing these unique lineages have
not been elucidated. This report identified a transcription factor
that is specifically expressed at high amounts in CD1d-restricted
invariant NKT cells and is essential for their development. Nota-
bly, PLZF was low or absent in other T cell populations of ab and
gd T cells expressing similar effector- and tissue-resident prop-
erties, including intestinal intraepithelial lymphocytes, in conven-
tional memory and effector CD4 and CD8 T cells generated
in vivo or in vitro, as well as in NK cells. Consistent with these
findings, PLZF did not appear to be required for the development
of any of these populations.
One important exception was the human MR1-restricted in-
variant MAIT cell lineage, which is most closely related to NKT
cells because of its usage of a semi-invariant canonical ab
TCR and its recognition of the MHC class I-like ligand MR1 on
hemopoietic cell types (Treiner and Lantz, 2006). MAIT cells
also express cytokine-secretion properties and phenotypic
markers of the memory, effector, and NK cell lineage, including
CD161 in humans. Due to the rarity of MAIT cells in the mouse,
it remains to be clarified whether PLZF is expressed in mouse
MAIT cells and whether it is necessary for their development.munity 29, 391–403, September 19, 2008 ª2008 Elsevier Inc. 397
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PLZF Directs NKT Cell DevelopmentFigure 5. Transgenic Expression of PLZF Converts CD4 Thymocytes into Effector Cells
(A) Left, CD4 and CD8 FACS dot plots of lymphocytes from various organs of CD4 promoter PLZF-transgenic and wild-type littermates (CD1d-aGC Tetramer-
positive cells are gated out). Right, CD44 and CD62L expression by CD4 cells of indicated organs gated as shown on the left panels. Percentages of cells in each
gate or quadrant are indicated. Data representative of two independent transgenic lines.
(B) PLZF-transgenic CD4 cells in competitive chimeras. Wild-type (CD45.1+) and PLZF Tg (CD45.2+, line 1797) bone marrow cells were mixed 1:1 to
reconstitute lethally irradiated wild-type recipients. Thymus and spleen cells were stained as indicated (left panels) to gate CD4+ and CD8+ T cells for
analysis of CD44 and CD45.1 (middle and right panels) Chimeras were analyzed 6.5 weeks after transfer. Data are representative of four individual
chimeras.
(C) Cell cycle analysis 3 hr after in vivo injection of 1 mg of 5-ethynyl-20-deoxyuridine (EdU) into mixed bone-marrow chimeras. EdU incorporation was
detected by intracellular flow cytometry for DP (left panels) and CD4 single positive (right panels) thymocytes of WT (top panels) and PLZF-Tg (bottom
panels) origin, as indicated. Numbers represent % EdU+. Similar values were obtained for splenic CD4+ cells (not shown). Data are representative of three
individual chimeras and two independent experiments.398 Immunity 29, 391–403, September 19, 2008 ª2008 Elsevier Inc.
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PLZF Directs NKT Cell DevelopmentFigure 6. Cytokine Profile of PLZF-Transgenic CD4 T Cells
(A) Intracellular flow cytometry with PLZF-specific mAb D-9 of thymic PLZF-transgenic (line 1797) CD4 SP cells compared with WT CD4 SP and with WT NKT
stage 1 + 2 cells thymocytes (Tetr+NK1.1-), as indicated.
(B) Decreased IL-2 secretion by PLZF-transgenic CD4+ T cells. CD4 cells were MACS-enriched from spleens of PLZF-transgenic and littermate and stimulated
with anti-CD3 + human IL-2 for two days. Values in pg/ml for 2 pairs of WT and Tg littermates, as indicated.
(C) Intracellular flow cytometry for IL-4 and IFN-g in littermate and PLZF-transgenic mice. Splenocytes were prepared and stimulated as in (B), with the addition of
brefeldin A for the last six hours of stimulation. Three pairs of WT and Tg littermates were analyzed. The percentages of dual IL-4 and IFN-g producers were 24.5,
17.3, 26.1 in transgenics versus 3.97, 4.92, 7.34 in WT.PLZF was induced very early in NKT cell development, as it
was found at intermediate amounts in CD24hi CD69hi CD1d-
aGalCer+ thymocytes, a population that includes DP and CD4
SP thymocytes that have just undergone positive selection by
CD1d ligands expressed in the cortex. The stimulation of posi-
tively selected NKT cell precursors differs from that of conven-
tional MHC-restricted thymocytes by at least two criteria. The li-
gands involved in NKT cell development have weak agonist
properties, as suggested by the weak stimulation of NKT hybrid-
omas cocultured with cortical thymocytes in vitro (Bendelac,
1995). One ligand that can fully stimulate NKT cells is the endog-
enous lipid iGb3 (Zhou et al., 2004), although other possible li-
gands remain to be characterized (Porubsky et al., 2007). In ad-
dition, homophilic interactions between SLAM family members
expressed by cortical thymocytes during TCR-ligand recognition
provide signaling through the adaptor SAP and Fyn that is essen-
tial to NKT cell development (Griewank et al., 2007). It is tempting
to speculate that some components of the SAP-Fyn signaling
pathway may be responsible for PLZF induction. However, we
have found that PLZF was still induced in signaled NKT thymo-
cytes in the absence of SAP. Furthermore, studies in patients
with the XLP syndrome associated with SAP deficiency suggest
that the development of MAIT cells is independent of SAP signal-
ing (O.L., unpublished results). Thus, the signal(s) leading to the
early induction of PLZF remain to be identified.
PLZF induction in early NKT cell precursors paralleled that of
c-Krox, a lineage determinating factor for the CD4 lineage. The
regulation of CD4 and CD8 expression by developing NKT cells
remains enigmatic. CD4 is unnecessary for the development or
function of NKT cells (Bendelac et al., 1994), yet it is expressed
on a large fraction of mature NKT cells, whereas CD8b is not ex-
pressed. By analogy with conventional CD4+ cells, it is hypothe-
sized that strong and persistent signaling by endogenous NKT
ligands results in c-Krox expression and CD4-lineage
commitment. Later, as developing NKT cells undergo cell divi-
sion and acquire the effector phenotype (stage 2), a fraction ofIthe CD4+ cells downregulate CD4 to become DN, a phenomenon
that has remained unexplained. Our unpublished results show
that these DN nevertheless maintain c-Krox expression.
Although the massive reduction of NKT cell numbers observed
in the absence of PLZF might have suggested developmental ar-
rest and death, detailed examination of the thymic precursors
and of the few residual CD1d tetramer-positive cells in peripheral
tissues suggested a more intriguing alternative explanation. NKT
cell precursors might be simply prevented from expanding and
acquiring the memory effector differentiation in the thymus,
whereas the minor population of their naive precursors was pre-
served. Thus, whereas PLZF-deficient NKT cells were nearly ab-
sent in the tissues where effector NKT cells are normally found,
such as the liver, the minor population of naive CD44lo NKT cells
could still be detected in the periphery, particularly in the periph-
eral lymph nodes due to their high expression of the homing re-
ceptor CD62L. In mixed bone-marrow chimeras, PLZF-deficient
NKT cells were as frequent as their wild-type counterparts in the
lymph nodes, whereas they were outnumbered 37 to 1 in the liver.
These arrested cells exhibited a cytokine profile reminiscent of
naive CD4+ cells, with high IL-2 and low IL-4 and IFN-g. Thus, al-
though PLZF is required for the expansion and effector differen-
tiation phase of NKT thymocyte development, its absence is
compatible with the survival and export of the earlier CD44lo
stage cells that resemble conventional CD4 SP cells. This conclu-
sion is intriguing because it might be expected that, due to their
autoreactive potential, such CD44lo cells should become acti-
vated by self antigen anyway. However, stimulation by naturally
expressed endogenous ligands is weak, because NKT cell hy-
bridomas exposed to CD1d expressing cells secrete low
amounts of cytokines compared to their maximal response. In
addition, it is possible that the amounts of endogenous NKT
cell ligands are downregulated in the periphery of healthy ani-
mals, as suggested by the observation that cortical thymocytes
are among the cell types most consistently capable of stimulating
NKT cell hybridomas (Park et al., 1998). Thus, as NKT cell(D) Frequency and tissue distribution of NKT cells in PLZF-transgenic mice. Data are from the same mixed bone-marrow chimeras as in Figure 5B and
represent percentages of NKT cells among wild-type (CD45.1+) and PLZF Tg (CD45.2+) lymphocytes.mmunity 29, 391–403, September 19, 2008 ª2008 Elsevier Inc. 399
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PLZF Directs NKT Cell DevelopmentFigure 7. PLZF Expression in Human NKT and MAIT Cells and in SAP-Deficient NKT Thymocytes
(A) Va7.2+CD45RO+CD161+ MAIT cells were purified from fresh human PBL according to their expression of CD4 or CD8b to measure the mRNA expression of
PLZF by quantitative qRT-PCR. The DN subset of MAIT cells is defined as CD4-CD8b-. Control Va7.2-RO+ memory cells were purified according to expression of
CD4 and CD8b. The Va7.2-RO+CD4-CD8b- (DN RO+) population is enriched in CD1d-restricted unconventional T cells.
(B) NKT cells were MACS-enriched from fresh human PBL using CD1d-aGC tetramer and FACS-sorted into total NKT cells or their CD4 and DN subsets to mea-
sure the mRNA expression of PLZF by quantitative qRT-PCR. The NKT-depleted MACS fraction was used to FACS purify naive (RA+) and memory (RO+) CD4 and
CD8 conventional T cells.
(C) PLZF expression by SAP-deficient ‘stage 0’ NKT thymocytes. 2000 CD1d-aGC+ thymocytes were sorted at different stages of NKT development for wild-type
mice and at the arrested ‘stage 0’ for SAP-deficient mice. PLZF mRNA expression was measured by quantitative qRT-PCR. Data summarize two independent
experiments. Control CD4 single positive (CDSP) are shown as negative control.precursors move from the thymic cortex into the medulla and
then migrate to the periphery, their stimulation by self ligands
may decrease. Alternatively, chronic stimulation in the periphery
might generate the minor population of stage 3 NKT cells found in
PLZF-deficient mice. A similar set of questions has been raised
about the autoreactivity of CD25+ regulatory T cells, because it
is not readily apparent, except after transfer of a regulatory
T cell TCR into cells that are subsequently injected into a lympho-
penic environment (Hsieh et al., 2004). Thus, these findings raise
the possibility that, in the healthy state, the weak autoreactivity of
NKT cells is more apparent in the thymus, where it serves signal-
ing functions for lineage specification, than it is in the periphery.
It is notable that ectopic expression of PLZF driven by the CD4
promoter (with the intronic silencer) changed the naive status of
conventional CD4-lineage cells and converted them into effec-
tor-type cells with migratory and cytokine properties reminiscent
of stage 2 NKT cells, including the signature IL-4 and IFN-g dual
production. Although the extent of this conversion, in particular
the influence of TCR specificity, remains to be fully investigated,
it appeared to be broad-based and cell-intrinsic, as evidenced
by the equivalent representation of PLZF-transgenic and WT
CD4 cells in 1:1 mixed bone-marrow chimeras and by the scar-
city of naive recirculating CD4 cells found in blood or lymph no-
des of PLZF-transgenic mice. Furthermore, preliminary analysis
suggested a normal polyclonal Vb repertoire similar to WT. The
conversion may occur in the thymus itself, given that only few
CD4 SP thymocytes exhibited the naive phenotype that charac-
terizes their WT counterparts. CD8+ T cells, however, failed to
convert despite the transient expression of PLZF at the DP stage,
suggesting a requirement for prolonged PLZF expression or, al-
ternatively, that the CD8 lineage may be refractory to PLZF. Alto-
gether, loss- and gain-of-function experiments establish the
central role of PLZF in directing the effector-differentiation pro-
gram of NKT cells. However, PLZF alone was not sufficient to
drive NKT cell differentiation all the way to the terminal NK cell-
like stage 3, indicating that additional factors controlling this later
stage remain to be discovered.400 Immunity 29, 391–403, September 19, 2008 ª2008 Elsevier Inc.PLZF is a member of the BTB/POZ-ZF family of transcriptional
regulators sharing a conserved BTB/POZ dimerization domain at
the N terminus, which can participate in homo- and heterodime-
rization, and a variable number of zinc-finger domains, responsi-
ble for DNA binding, at the C terminus. This family includes
c-Krox, which directs the CD4 lineage; LRF, which represses
T cell development in the bone marrow; and Bcl-6, MAZR,
BAZF, and ROG, which contribute to various aspects of lympho-
cyte development and function as well as to malignant hemopoi-
esis (reviewed in Bilic and Ellmeier, 2007; Kelly and Daniel, 2006).
These factors are characterized by their transcriptional repres-
sion through recruitment of a repressor complex consisting of
N-CoR, SMRT, sin3A/b, and histone deacetylases. PLZF is in-
volved in the pro-oncogenic translocation (11;17)(q23;q21) with
the retinoic acid receptor a (RARa) locus, which generates a fu-
sion protein consisting of the dimerization domains of PLZF and
the DNA-binding domains of RARa, resulting in the development
of acute promyelocytic leukemia as a result of myeloid precur-
sors failing to terminally differentiate (McConnell and Licht,
2007). PLZF expression has been found in some hematopoietic
cells, such as myeloid progenitors, but there is no report of he-
mopoietic defects in mice lacking PLZF. Instead, lack of PLZF
in the Luxoidmouse or in a targeted knockout resulted in the pro-
gressive loss of spermatogonial stem cells (Buaas et al., 2004;
Costoya et al., 2004), suggesting a role of PLZF in regulating cel-
lular proliferation and differentiation.
Given the highly specific expression and function of PLZF in
NKT cell development, further studies of the mechanisms under-
lying its induction and function will be warranted for the under-
standing of molecular events that specify this peculiar lineage.
EXPERIMENTAL PROCEDURES
Mice
Luxoid (B6.C3-Zbtb16Lu/J) mice were obtained from The Jackson Laboratory
and have been described elsewhere (Buaas et al., 2004). The Luxoid mutation
spontaneously arose on the C3H/He inbred strain and was backcrossed to
Immunity
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generations at The Jackson Laboratory. C57BL/6 (CD45.2) and B6.SJL-Ptprca
Pep3b/BoyJ (CD45.1) were from The Jackson Laboratory. B6.Ja18/ mice
have been described elsewhere (Cui et al., 1997), and the B6.Va14-Ja18 trans-
genic "414" mice and the B6.SAP/ mice were maintained in our laboratory
(Griewank et al., 2007). For the generation of PLZF-transgenic mice, PLZF
was PCR amplified from cDNA prepared from FACS-sorted C57BL/6 thymic
NKT cells and cloned into a plasmid containing the minimal CD4 promoter
and the intronic silencer (Sawada et al., 1994). The linearized construct was in-
jected into fertilized C57BL/6 oocytes, and the injected oocytes were im-
planted into pseudopregnant CD-1 (VAF+) outbred female mice. Transgenic
mice were screened with PCR (forward primer: 50-TGTGCCAGGGTCGGAGA
CAATAACGG-30; reverse primer: 50-TCCTGGCTGTCCACCATGATGACCAC-
30). Two founder lines, #1797 and #1960, were studied. All mice were raised
in a specific pathogen-free environment at the University of Chicago, and
experiments were performed in accordance with the guidelines of the Institu-
tional Animal Care and Use Committee.
Quantitative Real-time PCR
Total RNA was isolated from 20,000–100,000 FACS-sorted C57BL/6J primary
cells with a combination of Trizol (Invitrogen) and the RNeasy mini kit (QIAGEN,
Valencia, CA, USA) and was reverse-transcribed with random primers with the
use of the AffinityScript qPCR cDNA Synthesis Kit (Stratagene). Some popula-
tions were prepared with a mixture of random primers and oligo-d(T). For rare
stage 0 NKT thymocytes, pooled thymuses were first MACS-enriched with
CD1d-aGC tetramer and anti-APC beads with the use of autoMACS (Miltenyi
Biotech) and subsequently sorted directly into lysis buffer. From these lysates,
cDNA was prepared with the Cells-to-DNA II kit (Ambion) and random primers.
Transcripts for murine PLZF (Zbtb16) were quantified with the use of primers
spanning intron 4 (forward primer:50-CCCAGTTCTCAAAGGAGGATG-30; Re-
verse primer: 50-TTCCCACACAGCAGACAGAAG-30 ). Transcripts for murine
c-Krox (Zbtb7b) were quantified with the use of primers spanning intron 2 (for-
ward primer:50-ACTGGTGAGAAGCCCTTTGC-30; reverse primer: 50-
TTCCGCATGTGGATCTTCAG-30). Transcripts were normalized to 18 s ribo-
somal RNA (forward primer: 50-TTGACTCAACACGGGAAACC-30; reverse
primer: 50-ACCCACGGAATCGAGAAAGA-30).
For human NKT cell preparations, PBLs were MACS-enriched with CD1d-
aGC tetramers with the use of magnetic beads and were FACS sorted into total
NKT cells or their CD4 and DN subsets. Total RNA from approximately 53 104
cells was prepared a combination of Trizol (Invitrogen) and the RNeasy mini kit
(QIAGEN) and was reverse transcribed with Superscript III (Invitrogen) with
oligo-d(T). For human MAIT cell preparations, PBLs were stained and FACS
sorted as Va7.2+CD161+CD45RO+CD3+pan gd. MAIT subsets were further
purified with CD4 and CD8b. Control memory T cell fractions were defined
as CD3+gdVa7.2-CD45RO+ and further fractionated into CD4+CD8b,
CD4CD8b+, or CD4-CD8b (DN, including CD8aa). RNA from 200,000 cells
was purified and reverse transcribed with a combination of random primers
and oligo-d(T).
Transcripts for human PLZF were quantified with primers spanning intron 3
(forward primer: 50-TAGTTTGCGGCTGAGAATGC-30; reverse primer: 50-AC-
CGCACTGATCACAGACAAAG-30) and normalized to HPRT (forward primer:
50-GAAAGGGTGTTTATTCCTCATGG-30; reverse primer: 50-CTCCCATCTCC
TTCATCACATC-30 ).
All primers were generated using the Ensembl database and Primer3. Quan-
titative PCR was performed on a Stratagene Mx3005p using Brilliant SYBR
Green qPCR Master Mix (Stratagene).
SDS-PAGE and Western Blotting
Thymuses and spleens from C57BL/6J mice were pooled and MACS-enriched
for NKT cells with CD1d-aGC tetramers prior to FACS sorting, with a combina-
tion of CD1d-aGC tetramer, anti-TCRb, and anti-B220. Approximately 13 106
sorted cells were pelleted and frozen at80C until use. Cell pellets were lysed
on ice in TNE lysis buffer containing protease inhibitors and were separated
by SDS-PAGE on a 10% minigel. The gel was transferred to PVDF membrane
and blotted with a rabbit polyclonal antibody specific to the C-terminal region
of human PLZF (ab39354; Abcam) at a concentration of 0.4 mg/ml. Goat anti-
rabbit-HRP secondary antibody was applied at a concentration of 0.08 mg/ml
(111-036-003; Jackson ImmunoResearch), and HRP was detected by Chem-IiGlow West reagent (Alpha Innotech). For loading control, a g-tubulin specific
antibody (T6557; Sigma) was used at a 1:10,000 dilution of ascites.
Flow Cytometry
CD1d-aGalCer tetramers were prepared as previously described (Benlagha
et al., 2000). Fluorochrome-labeled monoclonal antibodies (clone indicated
in parentheses) against mouse B220 (RA3-6B2), CD1d (1B1), CD3e (17A2),
CD4 (GK1.5 or L3T4), CD8a (53-6.7), CD8b (53-5.8), CD11b (M170), CD11c
(HL3), CD21/35 (7G6), CD23 (B3B4), CD24 (M1/69), CD25 (PC61), CD45.1
(A20), CD45.2 (104), CD44 (IM7), CD62L (MEL-14), CD69 (H1.2F3), CD86
(GL-1), gdTCR (GL3), IA/IE (2G9), IL-4 (11B11), IFNg (XMG1.2), NK1.1
(PK136), and TCRb (H57-597) were purchased from eBioscience, BD Biosci-
ences, or BioLegend. Fluorochrome-labeled monoclonal antibodies against
human CD3 (UCHT1), CD4 (RPA-T4 or OKT4), CD8a (RPA-T8), CD8b
(2ST8.5H7), CD45RA (HI100), CD45RO (IM247 or UCHL1), CD161 (DX12),
pan gd (Immu 510), Va7.2 (3C10), and Va24 (C15) were purchased from eBio-
science, BD Biosciences, and Immunotech.
For NKT cell MACS enrichment, cells were labeled with APC-conjugated
CD1d-aGalCer tetramers, bound to anti-APC magnetic beads, and enriched
on an autoMACS cell separator (Miltenyi Biotech), as described previously
(Benlagha et al., 2005). Samples were analyzed on an LSRII (Becton Dickinson)
or sorted on FACSAria (Becton Dickinson) or MoFlo (Dako Cytomation), with
doublet exclusion and DAPI staining of dead cells in most experiments. For in-
tracellular flow cytometry of PLZF, thymocytes were first depleted of immature
cells with anti-CD24 and autoMACS before being stained for surface markers.
Cells were then washed and blocked with goat serum (Southern Biotech),
washed again and fixed with the permeabilization and fixation buffer ‘‘Foxp3
Staining Buffer Set’’ from eBioscience. Intracellular PLZF was detected with
4 mg/ml mouse monoclonal antibody D-9 (Santa Cruz) and FITC-conjugated
rat anti-mouse (eBioscience). Data was analyzed by FlowJo (Tree Star).
Cytokine Analysis
Cells were cultured on microplates coated with 10 mg/ml anti-CD3 (clone 145-
2C11) in the presence of 10 U/ml human IL-2 or were stimulated by irradiated
aGC-loaded bone-marrow-derived dendritic cells. Supernatants were stained
for cytokines with Mouse Grp I Cytokine 23-Plex Panel (Biorad) and assayed
with a Bioplex instrument. For intracellular flow cytometry, brefeldin A was
added for the final 6 hr of culture, and cells were permeabilized and stained
for IL-4 and IFN-g production with the BD BioSciences Cytofix/Cytoperm kit.
EdU Assay for Proliferation
Mice were injected intravenously (i.v.) with 1 mg of EdU (5-ethynyl-20-deoxyuri-
dine, Invitrogen) 3 hr before analysis. Thymocytes were processed and stained
for flow cytometry according to the manufacturer’s instructions.
Generation of Mixed Bone-Marrow Chimeras
Six- to eight-week-old B6.Ja18/ or B6 mice (CD45.2) were subjected to
900–950 Rads irradiation with a gamma cell 40 irradiator with a cesium source.
Three to six hr later, irradiated mice were injected i.v. with 2–10 3 106 bone
marrow cells obtained from femurs of B6.Zbtb16lu/lu or B6.CD4p-PLZF trans-
genics (CD45.2) and B6.CD45.1 and mixed at 1:1 or 3:1 ratios. Mice were
analyzed 6–9 wk after irradiation.
Statistical Analysis
Stastical analysis was performed in Prism (Graphpad Software) with the un-
paired t test for Luxoid mice and the paired t test for the mixed bone-marrow
chimeras.
SUPPLEMENTAL DATA
Supplemental data include Supplemental Experimental Procedures and one
figure and can be found with this article online at http://www.immunity.com/
cgi/content/full/29/3/391/DC1/.
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